Dr. Ranji Bindra explains the delicate balance that must go into treating the parents of patients in pediatric oncology.
Ranjit Bindra, MD, PhD, from Smilow Cancer Hospital at Yale explains the importance of communicating honestly and sensitively with parents when treating pediatric patients.
In pediatric oncology, nurses have to treat both the patient and the family. This requires a delicate balance that allows the parents to be hopeful and engaged, but realistic. Bindra highlights the importance of revising communication in relation to the patient's status.
FDA Approves Inotuzumab Ozogamicin for Pediatric Patients With ALL
March 6th 2024The antibody-drug conjugate inotuzumab ozogamicin was approved by the FDA for the treatment of patients aged 1 year and older with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia.
FDA Approves Inotuzumab Ozogamicin for Pediatric Patients With ALL
March 6th 2024The antibody-drug conjugate inotuzumab ozogamicin was approved by the FDA for the treatment of patients aged 1 year and older with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia.
2 Commerce Drive
Cranbury, NJ 08512